Published in Clin Exp Immunol on September 01, 2000
CD44 is the principal cell surface receptor for hyaluronate. Cell (1990) 11.01
Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies: differentiation antigens of rat lymphocytes. Cell (1977) 8.46
The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology (1985) 7.77
A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell (1991) 7.29
Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proc Natl Acad Sci U S A (1992) 4.90
CD44 and its interaction with extracellular matrix. Adv Immunol (1993) 4.04
Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science (1996) 3.84
Hyaluronate can function as a cell adhesion molecule and CD44 participates in hyaluronate recognition. J Exp Med (1990) 3.78
CD44: structure, function, and association with the malignant process. Adv Cancer Res (1997) 3.66
Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts. Mol Immunol (1987) 3.36
Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form. J Cell Sci (1990) 3.35
Participation in normal immune responses of a metastasis-inducing splice variant of CD44. Science (1992) 3.05
Characterization of the class III collagen receptor, a phosphorylated, transmembrane glycoprotein expressed in nucleated human cells. J Biol Chem (1988) 2.72
A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens. J Histochem Cytochem (1995) 2.71
Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms. Cancer Res (1994) 2.21
Prevention of tumor metastasis formation by anti-variant CD44. J Exp Med (1993) 2.03
Expression of transforming growth factor-beta isoforms in human glomerular diseases. Kidney Int (1996) 1.81
Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest (1999) 1.62
Structural homology between lymphocyte receptors for high endothelium and class III extracellular matrix receptor. Proc Natl Acad Sci U S A (1989) 1.61
In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int (1993) 1.49
Initiation and evolution of interstitial leukocytic infiltration in experimental glomerulonephritis. Kidney Int (1991) 1.35
Variant cell lines selected for alterations in the function of the hyaluronan receptor CD44 show differences in glycosylation. J Exp Med (1995) 1.35
Monoclonal antibodies to CD44 and their influence on hyaluronan recognition. J Cell Biol (1995) 1.31
Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J Cell Biol (1996) 1.31
Hyaluronan induces monocyte chemoattractant protein-1 expression in renal tubular epithelial cells. J Am Soc Nephrol (1998) 1.25
Antigenic differences between metastatic and nonmetastatic BSp73 rat tumor variants characterized by monoclonal antibodies. Cancer Res (1989) 1.18
Signaling through CD44 is mediated by tyrosine kinases. Association with p56lck in T lymphocytes. J Biol Chem (1996) 1.14
A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat. Proc Assoc Am Physicians (1998) 1.08
Variant exons v6 and v7 together expand the repertoire of glycosaminoglycans bound by CD44. J Biol Chem (1997) 1.06
Intrinsic renal cells are the major source of interleukin-1 beta synthesis in normal and diseased rat kidney. Nephrol Dial Transplant (1997) 1.05
De novo glomerular osteopontin expression in rat crescentic glomerulonephritis. Kidney Int (1998) 1.00
Delayed treatment with enalapril halts tubulointerstitial fibrosis in rats with obstructive nephropathy. Kidney Int (1996) 0.99
Characterization of CD44 induction by IL-1: a critical role for Egr-1. J Immunol (1999) 0.95
Osteopontin expression in fetal and mature human kidney. J Am Soc Nephrol (1999) 0.95
Two different functions for CD44 proteins in human myelopoiesis. J Clin Invest (1998) 0.91
Upregulated renal tubular CD44, hyaluronan, and osteopontin in kdkd mice with interstitial nephritis. Nephrol Dial Transplant (1997) 0.90
Developmentally regulated expression of metastasis-associated antigens in the rat. Cell Growth Differ (1996) 0.90
A novel ligand for CD44 is sulfated proteoglycan. Int Immunol (1994) 0.88
CD44 is an independent prognostic factor in conventional renal cell carcinomas. J Urol (1999) 0.87
De novo CD44 expression by proliferating mesangial cells in rat anti-Thy-1 nephritis. J Am Soc Nephrol (1996) 0.87
Accelerated immune response in transgenic mice expressing rat CD44v4-v7 on T cells. J Immunol (1996) 0.85
Expression of CD44 isoforms in human renal cell carcinomas. Virchows Arch (1996) 0.83
CD44 and hyaluronan expression in the development of experimental crescentic glomerulonephritis. Clin Exp Immunol (1997) 0.83
CD44 isoform expression mediated by alternative splicing: tissue-specific regulation in mice. Int Immunol (1994) 0.83
CD44 in glomerulonephritis: expression in human renal biopsies, the Thy 1.1 model, and by cultured mesangial cells. Kidney Int (1996) 0.81
Glomerular expression and cell origin of transforming growth factor-beta 1 in anti-glomerular basement membrane disease. Am J Med Sci (1994) 0.80
Engagement of variant CD44 confers resistance to anti-integrin antibody-mediated apoptosis in a colon carcinoma cell line. Cell Adhes Commun (1998) 0.80
Hyaluronate is a component of crescents in rat autoimmune glomerulonephritis. Lab Invest (1993) 0.79
Enhanced tubular epithelial CD44 expression in MRL-lpr lupus nephritis. Kidney Int (1996) 0.78
Tyrosine kinase activity is associated with CD44 in human neutrophils. FEBS Lett (1998) 0.77
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med (2001) 17.24
Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension (2001) 4.41
Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int (1999) 3.09
Early cellular events in a systemic graft-vs.-host reaction. II. Autoradiographic estimates of the frequency of donor lymphocytes which respond to each Ag-B-determined antigenic complex. J Exp Med (1975) 2.78
A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens. J Histochem Cytochem (1995) 2.71
The specific selection of recirculating lymphocytes by antigen in normal and preimmunized rats. J Exp Med (1972) 2.66
Specific unresponsiveness of recirculating lymphocytes ater exposure to histocompatibility antigen in F 1 hybrid rats. Nat New Biol (1971) 2.50
Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int (1998) 2.35
Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney Int (2006) 2.22
Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest (2001) 2.20
Tissue culture of isolated glomeruli in experimental crescentic glomerulonephritis. J Exp Med (1978) 2.02
Migration inhibitory factor expression in experimentally induced endotoxemia. Am J Pathol (1997) 2.00
The macrophagen in human rapidly progressive glomerulonephritis. Lancet (1976) 1.88
The pathogenic role of macrophage migration inhibitory factor in immunologically induced kidney disease in the rat. J Exp Med (1997) 1.86
Glomerulonephritis. Lancet (2005) 1.81
De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits. Circ Res (2000) 1.78
PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis. Kidney Int (2001) 1.69
Elevation of plasma level of macrophage migration inhibitory factor in patients with acute myocardial infarction. Am J Cardiol (2001) 1.65
Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest (1999) 1.62
Tubules are the major site of M-CSF production in experimental kidney disease: correlation with local macrophage proliferation. Kidney Int (2001) 1.60
Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int (1987) 1.60
The cDNA cloning and characterization of inositol polyphosphate 4-phosphatase type II. Evidence for conserved alternative splicing in the 4-phosphatase family. J Biol Chem (1997) 1.60
Early cellular events in a systemic graft-vs.-host reaction. I. The migration of responding and nonresponding donor lymphocytes. J Exp Med (1975) 1.57
Interleukin-1 induces tubular epithelial-myofibroblast transdifferentiation through a transforming growth factor-beta1-dependent mechanism in vitro. Am J Kidney Dis (2001) 1.56
Defective cytostatic activity of pulmonary alveolar macrophages in primary lung cancer. Chest (1990) 1.49
Antigenic heterogeneity of human mononuclear phagocytes: immunohistologic analysis using monoclonal antibodies. Blood (1983) 1.48
Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice. Diabetologia (2006) 1.42
Up-regulation of macrophage migration inhibitory factor in infants with acute neonatal necrotizing enterocolitis. Histopathology (2005) 1.42
De Novo renal expression of macrophage migration inhibitory factor during the development of rat crescentic glomerulonephritis. Am J Pathol (1996) 1.40
miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes. Diabetologia (2013) 1.39
Serum alpha 2-macroglobulin in haemodialysis patients: baseline and kinetic studies. Nephrol Dial Transplant (1993) 1.39
Renal protection by angiotensin II receptor antagonists in patients with type 2 diabetes. Med J Aust (2001) 1.39
Australians with renal disease: a new national survey. Med J Aust (1999) 1.38
The role of macrophages in glomerulonephritis. Nephrol Dial Transplant (2001) 1.38
Initiation and evolution of interstitial leukocytic infiltration in experimental glomerulonephritis. Kidney Int (1991) 1.35
Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation. Am J Pathol (1993) 1.35
Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis. Am J Kidney Dis (2001) 1.34
Targeting the IL-15 receptor with an antagonist IL-15 mutant/Fc gamma2a protein blocks delayed-type hypersensitivity. J Immunol (1998) 1.32
The macrophage in the development of experimental crescentic glomerulonephritis. Studies using tissue culture and electron microscopy. Am J Pathol (1979) 1.31
The incidence of biopsy-proven glomerulonephritis in Australia. Nephrol Dial Transplant (2001) 1.30
The effect of defibrination on macrophage participation in rabbit nephrotoxic nephritis: studies using glomerular culture and electronmicroscopy. Clin Exp Immunol (1979) 1.28
Local macrophage proliferation in human glomerulonephritis. Kidney Int (1998) 1.26
Suppression of experimental crescentic glomerulonephritis by the interleukin-1 receptor antagonist. Kidney Int (1993) 1.22
Aggresome-forming TTRAP mediates pro-apoptotic properties of Parkinson's disease-associated DJ-1 missense mutations. Cell Death Differ (2008) 1.20
Expression of macrophage migration inhibitory factor in human glomerulonephritis. Kidney Int (2000) 1.20
Composition of interstitial cellular infiltrate identified by monoclonal antibodies in renal biopsies of rejecting human renal allografts. Transplantation (1983) 1.19
Membrane antigens of human cells of the monocyte/macrophage lineage studied with monoclonal antibodies. Pathology (1983) 1.17
Immunohistological studies with monoclonal antibodies. Methods Enzymol (1986) 1.16
Immunohistological analysis of serial biopsies taken during human renal allograft rejection. Changing profile of infiltrating cells and activation of the coagulation system. Transplantation (1985) 1.16
Tissue culture of isolated human glomeruli. Pathology (1978) 1.15
A comparison of fixatives and immunohistochemical technics for use with monoclonal antibodies to cell surface antigens. Am J Clin Pathol (1982) 1.15
CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer. Oncogene (2012) 1.14
Identification of a major sialoprotein in the glycocalyx of human visceral glomerular epithelial cells. J Clin Invest (1986) 1.13
Membranous nephropathy and thromboembolism: is prophylactic anticoagulation warranted? Nephron (1993) 1.12
Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis. Cancer Res (2009) 1.11
The proportion of lymphocytes capable of recognizing strong transplantation antigens in vivo. Adv Exp Med Biol (1973) 1.10
MIF expression in the rat brain: implications for neuronal function. Mol Med (1998) 1.10
Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation. Nephrol Dial Transplant (1999) 1.10
A simple, reliable, and sensitive method for nonradioactive in situ hybridization: use of microwave heating to improve hybridization efficiency and preserve tissue morphology. J Histochem Cytochem (1996) 1.10
Modulators of crescentic glomerulonephritis. J Am Soc Nephrol (1996) 1.09
Macrophage migration inhibitory factor is an important mediator in the pathogenesis of gastric inflammation in rats. Gastroenterology (2001) 1.09
A functional role for osteopontin in experimental crescentic glomerulonephritis in the rat. Proc Assoc Am Physicians (1998) 1.08
Cellular immune mechanisms in human glomerulonephritis: the role of mononuclear leucocytes. Springer Semin Immunopathol (1982) 1.07
Campylobacter peritonitis in continuous ambulatory peritoneal dialysis: report of eight cases and a review of the literature. Am J Kidney Dis (1992) 1.07
Kidney-targeting Smad7 gene transfer inhibits renal TGF-β/MAD homologue (SMAD) and nuclear factor κB (NF-κB) signalling pathways, and improves diabetic nephropathy in mice. Diabetologia (2011) 1.06
Involvement of activated periglomerular leukocytes in the rupture of Bowman's capsule and glomerular crescent progression in experimental glomerulonephritis. Lab Invest (1992) 1.05
Intrinsic renal cells are the major source of interleukin-1 beta synthesis in normal and diseased rat kidney. Nephrol Dial Transplant (1997) 1.05